A non-biodegradable device intended to be temporarily placed via a nostril into the nasal cavity after surgery or trauma to help minimize bleeding by tamponade effect, prevent adhesions between the mucosal surfaces, and/or provide support to the surrounding ti
| Company | Devices | Share |
|---|---|---|
| Invotec International, Inc. | 94 | 23% |
| Spiggle & Theis Medizintechnik Gmbh | 45 | 11% |
| Boston Medical Products, Inc. | 41 | 10% |
| Summit Medical, Inc. | 39 | 10% |
| Cranio Mandibular Rehab, Inc. | 35 | 9% |
| Medtronic Xomed, Inc. | 25 | 6% |
| Stryker Leibinger Gmbh & Co. Kg | 24 | 6% |
| Aegis Lifesciences Private Limited | 24 | 6% |
| First Aid Bandage Co Inc | 17 | 4% |
| Exmoor Plastics Limited | 15 | 4% |
| Network Medical Products Limited | 10 | 2% |
| Eon Meditech Private Limited | 9 | 2% |
Company = labeler of record on GUDID. 24 companies in total; top 12 shown. Click headers to sort.
Sample of brand names as labelled; no endorsement. Ask us for the full list with company, model and UDI.
| Code | Name | Devices |
|---|---|---|
| LYA | Splint, Intranasal Septal | 276 |
| LYA | SPLINT, INTRANASAL SEPTAL | 102 |
| EMX | Balloon, Epistaxis | 70 |
| EPP | Splint, Nasal | 49 |
| NAB | Gauze / Sponge,Nonresorbable For External Use | 34 |
| EMX | BALLOON, EPISTAXIS | 7 |
Use these as the dimensions to specify in a tender line.
407 device records in commercial distribution are listed on the FDA Global Unique Device Identification Database (GUDID) under the GMDN category "Intranasal splint, non-biodegradable", from 24 companies. The largest labeler is Invotec International, Inc. with 23% of records.
LYA (Splint, Intranasal Septal), LYA (SPLINT, INTRANASAL SEPTAL), EMX (Balloon, Epistaxis), EPP (Splint, Nasal)
No. GUDID is the US register. For the UAE (MOHAP/DoH) and Saudi (SFDA/MDMA) a separate registration and a local authorised representative are required; Consulting Wallah can check the status and connect you with registered suppliers.
Add intranasal splint, non-biodegradable to the RFQ basket or use the form below with quantity, specification and delivery location; the Network returns comparable quotes from verified suppliers in 2–5 working days.
Hospitals, pharmacies and distributors anywhere: tell us what you need and the Consulting Wallah Network returns comparable quotes from verified suppliers. No fee for buyers.
Source: FDA AccessGUDID (AccessGUDID full release 2 Nov 2026); counts are device records in commercial distribution grouped by GMDN preferred term; companies are labelers of record. Information only — US listing is not a registration in the UAE or GCC; verify with the regulator. © Consulting Wallah — CC BY‑NC‑ND.